← Back to Search

Eyes with abnormal anterior segment for Cataract

N/A
Recruiting
Led By Jeffrey Fischer, MD
Research Sponsored by Heidelberg Engineering GmbH
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 day
Awards & highlights

Summary

This study is conducted to compare the the investigational device ANTERION with software version 1.5 against the ANTERION with software version 1.2.4 (cleared version)

Eligible Conditions
  • Cataract
  • Healthy Eyes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Anterior Chamber Depth
Axial Length
Central Cornea Thickness
+2 more
Secondary outcome measures
Adverse Events Rate

Trial Design

2Treatment groups
Experimental Treatment
Group I: Eyes with normal anterior segmentExperimental Treatment1 Intervention
Group II: Eyes with abnormal anterior segmentExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Heidelberg Engineering GmbHLead Sponsor
18 Previous Clinical Trials
2,239 Total Patients Enrolled
1 Trials studying Cataract
176 Patients Enrolled for Cataract
Jeffrey Fischer, MDPrincipal InvestigatorFischer Laser Eye Center
~33 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top